Tempest Therapeutics, Inc.

TPST · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$42-$29-$36-$28
Dep. & Amort.$0$0$1$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$5$3$2$1
Change in WC$2-$3$1-$1
Other Non-Cash$2$2$2$1
Operating Cash Flow-$33-$27-$31-$26
Investing Activities
PP&E Inv.-$0-$0-$1-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0-$1-$0
Financing Activities
Debt Repay.-$4$0-$5$15
Stock Issued$29$36$9$33
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$7$11
Financing Cash Flow$25$36$11$59
Forex Effect$0$0$0$0
Net Chg. in Cash-$9$8-$20$33
Supplemental Information
Beg. Cash$40$32$52$19
End Cash$31$40$32$52
Free Cash Flow-$33-$28-$32-$26